Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways
Nesma M.E. Abo El- Nasr, Dalia O. Saleh, Sawsan S. Mahmoud, Salwa M. Nofal, Rania M. Abdelsalam, Marwa M. Safar, Hanan S. El‐Abhar
Topics & Concepts
OlmesartanEndocrinologyAdiponectinInternal medicinePioglitazoneMedicineInsulin resistanceDiabetes mellitusOxidative stressType 2 diabetesLeptinTelmisartanObesityBlood pressureLiver Disease Diagnosis and TreatmentAdvanced Glycation End Products researchDiet, Metabolism, and Disease